CRITICAL CARE CLINICS is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, focusing on advancing knowledge in the fields of Critical Care and Intensive Care Medicine. With an impressive impact factor and designated as Q1 in both Critical Care and Intensive Medicine categories, this journal is a leading resource for healthcare professionals, researchers, and students alike. Since its establishment in 1985, it has evolved into an essential conduit for cutting-edge research, clinical insights, and evidence-based practices, bridging the gap between theoretical understanding and practical application in critical care. The journal maintains a high ranking, being positioned 15th of 110 in its category according to Scopus, with a noteworthy percentile of 86, indicating its influence and relevance in contemporary medical discourse. Although the journal is not open access, it provides valuable content for those dedicated to enhancing patient care and advancing the science of critical medicine. Its commitment to excellence makes it a vital resource for anyone engaged in the dynamic field of critical care.

The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.

Annals of Intensive Care is a premier, peer-reviewed journal dedicated to advancing the field of critical care and intensive care medicine. Published by Springer since 2011, this open-access journal is renowned for disseminating high-quality research and clinical studies that inform and influence practice in intensive care settings worldwide. With an impressive impact factor and a prestigious Q1 ranking in its category, it ranks #6 out of 110 in Critical Care and Intensive Care Medicine, placing it in the 95th percentile of its field according to Scopus. The journal aims to foster collaboration among researchers, clinicians, and policymakers by providing a platform for innovative research findings, case studies, and thought-provoking reviews. Addressed to an international audience committed to improving patient outcomes in critical care, Annals of Intensive Care plays a crucial role in shaping the future of intensive care medicine with its commitment to excellence in research and scholarship.

Signa Vitae is a distinguished academic journal published by MRE PRESS, focusing on critical care, intensive care medicine, and emergency medicine. Established in 2008 and running through 2024, this journal serves as an essential conduit for the dissemination of innovative research and clinical practices in these dynamic fields. Based in Croatia, Signa Vitae is indexed in Scopus, highlighting its importance within the scholarly community, boasting respectable quartiles with a Q3 ranking in both Critical Care and Intensive Care Medicine and Emergency Medicine as of 2023. Although it operates under a traditional access model, the journal aims to enhance knowledge sharing and interdisciplinary dialogue among researchers, healthcare professionals, and students globally, addressing the urgent challenges and advancements in patient care. By providing a platform for high-quality studies and reviews, Signa Vitae continues to advance the conversation and practice within critical and emergency medicine.

Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.

HEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.

Therapeutic Advances in Pulmonary and Critical Care Medicine is a leading journal published by SAGE Publications Ltd, dedicated to advancing the fields of pulmonary and critical care medicine. With an emphasis on innovative research, clinical practice, and therapeutic strategies, this journal aims to provide an essential platform for professionals, researchers, and students alike to share groundbreaking findings and insights in a rapidly evolving medical landscape. As an Open Access publication, it ensures that high-quality research is easily accessible to a global audience, facilitating knowledge sharing and collaboration. Though specific metrics such as H-Index and Scopus rankings are currently unlisted, the journal's commitment to rigorous peer review and high academic standards positions it as a vital resource for anyone involved in pulmonary and critical care medicine. With its dedicated editorial board and a diverse array of topics covered, Therapeutic Advances in Pulmonary and Critical Care Medicine stands at the forefront of fostering the latest advancements in the field.

Respiratory Care is a leading journal in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, published by DAEDALUS ENTERPRISES INC. With a history dating back to 1973 and continuing through 2024, this journal serves as a vital platform for disseminating innovative research findings, clinical practices, and advancements in respiratory healthcare. The journal is recognized for its impact, reflected in its impressive Q2 quartile rankings across several categories in 2023, demonstrating its relevance and influence in the medical community. Although it is not an Open Access publication, it provides critical insights and foster discussions aimed at enhancing patient care and treatment protocols for respiratory diseases. The journal is indexed in notable databases, ensuring wide visibility and accessibility of its content to researchers, professionals, and students dedicated to advancing knowledge and practice in respiratory care.

Intensive Care Medicine Experimental is a premier open-access journal dedicated to advancing research and clinical practice within the realms of critical care, intensive care medicine, and emergency medicine. Published by SPRINGER, this influential journal has been committed to dispensing high-quality, peer-reviewed research since its inception in 2013, reflecting its progressive approach to open-access publishing and enhancing global accessibility to vital medical information. With a notable impact factor and categorically established Q1 rankings in both Critical Care and Emergency Medicine, as well as Q2 in Physiology (medical), the journal underscores its significance in disseminating groundbreaking studies and innovations. Positioned prominently within the medical literature, Intensive Care Medicine Experimental ranks 16th in Emergency Medicine and 27th in Critical Care, providing a vital platform for researchers, clinicians, and students alike to explore and share cutting-edge research findings that aim to improve patient outcomes. The journal's dedication to fostering collaboration and dialogue among professionals makes it an essential resource in the evolving landscape of intensive care and emergency medical disciplines.

Medicina Intensiva is a distinguished journal published by Elsevier España SLU, specializing in the critical care and intensive medicine fields. Since its inception in 1988, this peer-reviewed journal has established itself as a vital resource for healthcare professionals and researchers dedicated to advancing the knowledge and treatment of critically ill patients. With an impact factor ranked in the Q2 category for Critical Care and Intensive Care Medicine, the journal sits at the 50th percentile among its peers, reflecting its reputable standing in the academic community. The scope of the journal encompasses a wide array of topics, from clinical practices to innovative research findings, contributing significantly to the enhancement of patient care in intensive settings. Although the journal does not currently offer Open Access options, its valuable content is accessible to subscribers and institutions, reinforcing its role as an important conduit for disseminating high-quality research. As we continue into 2024, *Medicina Intensiva* remains committed to supporting the medical community through insightful articles and timely reviews that shape the future of intensive care.